Bright Minds Biosciences (DRUG) Debt to Equity (2019 - 2026)
Bright Minds Biosciences (DRUG) debt to equity from Dec 31, 2019 to Mar 31, 2026. The current Bright Minds Biosciences (DRUG) debt to equity is 0.03%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Debt to Equity
Debt to Equity
Annual Debt to Equity change of Bright Minds Biosciences (DRUG)
| Year | Debt to Equity | Change |
|---|---|---|
| 2025 | 0.16% | -92.68% |
| 2024 | 2.17% | +104.23% |
| 2023 | 1.06% | -20.15% |
| 2022 | 1.33% | N/A |
| 2021 | 0.00% | N/A |
| 2020 | 0.00% | N/A |
| 2019 | 0.00% | N/A |
Comparison Bright Minds Biosciences (DRUG) debt to equity with competitors
Bright Minds Biosciences (DRUG) debt to equity is 0.03%.